Premera-Blue Cross has listed policy 7.01.97, “Intracoronary Drug Delivery Balloon Procedures,” among multiple policies open for stakeholder feedback with a submission deadline of March 5, 2026. The notice is an index entry only and contains no coverage criteria, coding guidance, prior authorization rules, or clinical details for intracoronary drug delivery balloons. This listing reflects inclusion in a broader review cycle alongside many other medical and surgical policies, not a specific substantive policy change. No contact, submission instructions, effective date, or indication of whether this is a new, revised, or reissued policy are provided in the excerpt.
March 5, 2026 Notice: Inclusion of `7.01.97` Intracoronary Drug Delivery Balloon Procedures for Review
This document is an announcement of multiple upcoming or under-review policies with a request for feedback by March 5, 2026. For this list, the item specifically related to cardiology and vascular interventions is 7.01.97, Policy Title = Intracoronary Drug Delivery Balloon Procedures. No detailed coverage criteria, coding, or clinical guidance for intracoronary drug delivery balloon procedures are included in the provided text. The change presented is the inclusion of 7.01.97 in the roster of policies open for review rather than substantive modifications to the policy language itself.
The source lists 1.01.508 and many other policy numbers alongside 7.01.97, indicating these items are grouped together for stakeholder feedback. The only time-sensitive element is the feedback deadline of March 5, 2026.
Scope of Information Provided for `7.01.97`
The document functions as an index of policies rather than a full policy text; 7.01.97 appears only as an entry in a list of policies soliciting feedback. No definitions, indications, exclusions, or benefit language for Intracoronary Drug Delivery Balloon Procedures are provided in the source. Consequently, there is no content in this notice that describes clinical scenarios, patient selection criteria, or procedural details for intracoronary drug delivery balloons.
Because the listing is limited to the policy title and number, no statements about coding (for example, CPT or HCPCS codes), prior authorization requirements, or member cost-sharing are contained in this announcement.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.